TAKE Solutions announces Q1 FY20 results, reports 24.6% Y-o-Y growth

Revenue up 24.6% Y-o-Y to INR 5,827.4 Mn, Operating EBITDA at INR 1,095.5 Mn

Chennai, August 08, 2019:TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized domain intensive services provider in Life Sciences, today announced its Q1 FY20 financial results. The company posted quarterly revenue of INR 5,827.4 Mn, registering a growth of 9.1% compared to the previous quarter.

Consolidated Financial Highlights – Figures in INR Million

The reported Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) for Q1FY20 stood at INR 1,103.7 Mn, as against INR 830.2 Mn after considering all one-time expenses in the previous quarter.

Srinivasan H R, Vice Chairman and Managing Director, TAKE Solutions said, “TAKE has seen strong numbers in terms of revenue growth this. We are on track in terms of our vision to be a 500 million-dollar enterprise by 2021 and have achieved USD 83.6 Mn this quarter. Company sustained its growth in revenues and profits on account of the business strengthening initiatives of the earlier years that now came to fruition.”

He also added, ”As a Life Sciences company actively engaged in R&D, we have been reclassified under the Pharmaceuticals Industry on both the BSE and NSE.”

Key Highlights:

  • 2 of the Top 5 Pharma companies have renewed Long Term Multi-million-dollar contracts till 2022
  • TAKE’s key brand Navitas Life Sciences is recognized as a Major Contender within 3 years of launching as a full-service Clinical Research Organization by Everest Group PEAK Matrix Assessment 2019

About TAKE Solutions

TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management.

In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Our range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Our global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.

With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange. Led by a team of industry stalwarts and domain experts, TAKE has been growing steadily with FY19 revenues touching INR 20,390 Mn, (USD 292 Mn).

For more details, please visit www.takesolutions.com.

For media information::
Rajeswari Kumar, TAKE Solutions, +91 44 66110700, This email address is being protected from spambots. You need JavaScript enabled to view it.


Registered Office

No. 27, Tank Bund Road,
Chennai - 600034, India

Email : contact@takesolutions.com

Phone : +91 44 6611 0700/701

©2022 TAKE Solutions Limited